AlphaGen Therapeutics
Shanghai · Founded 2022
About AlphaGen Therapeutics
AlphaGen Therapeutics is a biotechnology company that focuses on innovative radioligand therapies for cancer treatments.
Company Facts
- Founded: 2022
- Legal name: Shanghai Hezhou Medicine Co., Ltd.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Funding stage: Early Stage Venture
- Last round: Series A (Aug 2025)
- Website: alphagentx.com
- Phone: [email protected]
Canonical: https://fsome.com/organization/alphagen-therapeutics-8341580 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.